Risk factors for the development of pneumonia in patients with immuno-inflammatory rheumatic diseases receiving GIBP in conditions of COVID-19

A retrospective analysis of the database of the register of patients with immuno-inflammatory rheumatic diseases receiving treatment with biologic disease-modifying anti-rheumatic drugs in the Novosibirsk region was carried out, which included 318 patients, 94 of whom had indications of pneumonia dur...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Y. D. Kurochkina, M. A. Korolev, E. A. Letyagina, N. E. Banshchikova, A. E. Sizikov, L. A. Bogoderova, Y. B. Ubshaeva, V. O. Omelchenko, A. A. Akimova, A. A. Mullagaliev, O. A. Chumasova, N. A. Ilyina
Formato:	Artigo
Idioma:	Russo
Publicado em:	Yakut Science Center of Complex Medical Problems 2025-02-01
coleção:	Якутский медицинский журнал
Assuntos:	covid-19 pneumonia immune-inflammatory rheumatic diseases biologic disease-modifying anti-rheumatic drugs
Acesso em linha:	https://ymj.elpub.ru/jour/article/view/209
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!